Plain-English translation of NCT07834736 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying the Fortilink-TS Ti, a cage-shaped implant placed in the lower spine during fusion surgery. The study will follow about 50 patients for one year after surgery to make sure the implant is safe and works well for treating degenerative disc disease (wear and tear of the spine) and mild slippage of vertebrae.
Even though this implant has been used in patients since 2020, the manufacturer wants to gather more real-world information about how well it performs and any safety concerns in the specific group of patients it's designed for.
You likely qualify if…
You likely don't qualify if…
You would receive standard spinal fusion surgery with the Fortilink-TS Ti implant at one of two participating hospitals. The study simply involves collecting information about your medical history before surgery, details from the surgery itself, and your recovery over one year. You'll attend the same follow-up visits and receive the same care as patients having this surgery outside the study—nothing extra or experimental.
AI-generated summary from trial data · Nov 14, 2026 · Not medical advice
Spain